Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: ‘PRIDE’ Complex

Epidermal growth factor receptor (EGFR) inhibitor therapy has become the standard treatment for non-small cell lung cancer and head neck malignancy. This class of drug comprises EGFR inhibitors (erlotinib and gefitinib) and monoclonal antibody (cetuximab). Use of this class of drugs has been associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Madke, Bhushan, Gole, Prachi, Kumar, Prabhash, Khopkar, Uday
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037949/
https://www.ncbi.nlm.nih.gov/pubmed/24891659
http://dx.doi.org/10.4103/0019-5154.131398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037949/
https://www.ncbi.nlm.nih.gov/pubmed/24891659
http://dx.doi.org/10.4103/0019-5154.131398

Ejemplares similares